skip to Global Navigation Bar skip to main content


homeHome > In-License > Strategy

 Strategy

Daewoong accomplishes fast market penetration of licensed products by simultaneously conducting multi-national clinical trials (PII, PIII) with licensors.


Daewoong maximizes market resource utilization by introducing products in therapeutic fields with strong marketing power and by promoting co-prescription with our existing products.


Daewoong offers various business options to our partners such as co-marketing, co-promotion, joint-ventures and equity investment. These models are based on the needs of our business partners.